TEV-56248, Albuterol sulfate — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-31 in 3mo
ESTIMATED |
READOUT
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol
Phase 3 · Asthma |
Teva Branded Pharmaceutical Produc | TEV-56248, Albuterol sulfate |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|